Vaxart, Inc. - VXRT
About Gravity Analytica
Recent News
- 06.13.2025 - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
- 06.13.2025 - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
- 06.13.2025 - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
- 06.11.2025 - Vaxart Norovirus Phase 1 Topline Data Conference Call
- 06.11.2025 - Vaxart Norovirus Phase 1 Topline Data Conference Call
- 06.11.2025 - Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
- 06.11.2025 - Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
- 06.11.2025 - Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
- 06.10.2025 - Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
- 06.10.2025 - Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial